TABULA RASA HEALTHCARE,INC (NASDAQ:TRHC) Files An 8-K Other Events
Item 8.01 Other Events.
Loan Agreement Amendment
As previously disclosed, Tabula Rasa HealthCare,Inc., a Delaware corporation (“TRHC”), CareKinesis,Inc., a Delaware corporation (“CareKinesis”), Careventions,Inc., a Delaware corporation (“Careventions”), Capstone Performance Systems, LLC, a Delaware limited liability company (“Capstone”), J.A. Robertson,Inc., a California corporation (“Robertson”), Medliance LLC, an Arizona limited liability company (“Medliance”), CK Solutions, LLC, a Delaware limited liability company (“CK Solutions”), TRSHC Holdings, LLC, a Delaware limited liability company (“TRSHC”), SinfoniaRx,Inc., an Arizona corporation (“SinfoniaRx”), TRHC MEC Holdings, LLC, a Delaware limited liability company (“TRHC MEC”), Mediture LLC, a Minnesota limited liability company (“Mediture”), eClusive L.L.C., a Minnesota limited liability company (“eClusive”), TRHC DM Holdings, LLC, a Delaware limited liability company (“TRHC DM”) and Cognify, LLC, a Delaware limited liability company (“Cognify” and, together with TRHC, CareKinesis, Careventions, Capstone, Robertson, Medliance, CK Solutions, TRSHC, SinfoniaRx, TRHC MEC, Mediture eClusive and TRHC DM, the “Borrowers”) entered into a Loan and Security Modification Agreement (the “Amendment”) with the several banks and other financial institutions or entities party thereto (the “Lenders”) and Western Alliance Bank, an Arizona corporation, as a Lender and as administrative agent and collateral agent for the Lenders (the “Agent”) on February7, 2019. The Amendment amends that certain Amended and Restated Loan and Security Agreement, dated September6, 2017, by and among the Borrowers, the Lenders and the Agent, in connection with TRHC’s previously announced offering of convertible senior subordinated notes due 2026 in a private placement to qualified institutional buyers (the “Convertible Note Offering”) to Rule144A under the Securities Act of 1933, as amended (the “Securities Act”). The foregoing description of the Amendment does not purport to be complete and is qualified in its entirety by reference to the Amendment, which is filed as Exhibit10.2 to this Current Report on Form8-K and incorporated herein by reference.
Convertible Note Offering
On February8, 2019, TRHC issued a press release announcing the pricing of the Convertible Note Offering. A copy of the press release is attached hereto as Exhibit99.1 and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
|
ExhibitNumber |
Description |
|
10.1 |
Loan and Security Modification Agreement, entered into as of October19, 2018, by and among CareKinesis,Inc., Tabula Rasa HealthCare,Inc., Careventions,Inc., Capstone Performance Systems, LLC, J.A. Robertson,Inc., Medliance LLC, CK Solutions, LLC, TRSHC Holdings, LLC, SinfoniaRx,Inc., TRHC MEC Holdings, LLC, Mediture, LLC and eClusive L.L.C., the several banks and other financial institutions or entities party thereto, and Western Alliance Bank, as a Lender and as administrative agent and collateral agent for the Lenders. |
Tabula Rasa HealthCare, Inc. Exhibit
EX-10.1 2 a19-4210_2ex10d1.htm EX-10.1 Exhibit 10.1 LOAN AND SECURITY MODIFICATION AGREEMENT This Loan and Security Modification Agreement (this “Amendment”),…
To view the full exhibit click here
About TABULA RASA HEALTHCARE,INC (NASDAQ:TRHC)
Tabula Rasa HealthCare, Inc. (Tabula Rasa), formerly CareKinesis, Inc., is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs. It also provides risk adjustment services, which help its clients to properly characterize a patient’s acuity, or severity of health condition, and optimize the associated payments for care. The Company serves approximately 100 healthcare organizations that focus on populations with complex healthcare needs and extensive medication requirements. Its products and services are built around the Medication Risk Mitigation Matrix, or MRM Matrix.
